Share

November 30, 2021; 97 (22) Video NeuroImage

Bing-Neel Syndrome

A Rare Mimic of Secondary Normal Pressure Hydrocephalus

Yosef Ellenbogen, Afnan Al-Khotani, David Tang-Wai, Alfonso Fasano, Ronit Agid, Mojgan Hodaie
First published October 11, 2021, DOI: https://doi.org/10.1212/WNL.0000000000012917
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
537

Share

Article Information

vol. 97 no. 22 1033-1034
DOI: 
https://doi.org/10.1212/WNL.0000000000012917
PubMed: 
34635562
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 11, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Yosef Ellenbogen, MD,
    2. Afnan Al-Khotani, MD,
    3. David Tang-Wai, MD,
    4. Alfonso Fasano, MD,
    5. Ronit Agid, MD and
    6. Mojgan Hodaie, MD
  1. Yosef Ellenbogen, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Afnan Al-Khotani, MD,
    3. Scientific Advisory Boards:

    1. Commercial entities: Abbvie, Boston Scientific, Sunovion and Ipsen.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Commercial entities: UCB pharma, Medtronic, Abbvie, Chiesi Farmaceutici, TEVA, Boston Scientific, Ipsen

    Editorial Boards:

    1. Editorial board member of Movement Disorders, Movement Disorders Clinical Practice and Parkinsonism and Related Disorders

    Patents:

    1. NONE

    Publishing Royalties:

    1. Book

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Medtronic, Abbvie, Abbott, Ceregate, Boston Scientific

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Chiesi Pharmaceutics, Boston Scientific, Medtronic

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Neureca Onlus, AFaR, the Division of Neurology - University of Toronto and the Michael J. Fox Foundation, Weston Foundation Chair in Neuromodulation and Multidisciplinary Care

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. David Tang-Wai, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Alzheimer Society Canada - research grant, co- investigator - no salary support

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Alfonso Fasano, MD,
    5. Scientific Advisory Boards:

    1. Commercial entities: Abbvie, Boston Scientific, Sunovion and Ipsen.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Commercial entities: UCB pharma, Medtronic, Abbvie, Chiesi Farmaceutici, TEVA, Boston Scientific, Ipsen

    Editorial Boards:

    1. Editorial board member of Movement Disorders, Movement Disorders Clinical Practice and Parkinsonism and Related Disorders

    Patents:

    1. NONE

    Publishing Royalties:

    1. Book

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Medtronic, Abbvie, Abbott, Ceregate, Boston Scientific

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Chiesi Pharmaceutics, Boston Scientific, Medtronic

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Neureca Onlus, AFaR, the Division of Neurology - University of Toronto and the Michael J. Fox Foundation, Weston Foundation Chair in Neuromodulation and Multidisciplinary Care

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Ronit Agid, MD and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Mojgan Hodaie, MD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. speaker honorarium, Medtronic(C)

    Editorial Boards:

    1. Academic Editor, PLoS ONE Editorial Board, Stereotactic and Functional Neurosurgery Editorial Board, Journal of Neurosurgery

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Previous research funding by Medtronic Research funding by ELEKTA

    Clinical procedures or imaging studies:

    1. Surgery for idiopathic intracranial hypertension

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Grants from CIHR Grants from Fujitsu

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Divisions of Neurosurgery (Y.E., A.A.-K., M.H.) and Neurology (D.T.-W., A.F.), University of Toronto; Krembil Brain Institute (D.T.-W., A.F., M.H.); Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic (A.F.) and Division of Neuroradiology, Joint Department of Medical Imaging (R.A.), Toronto Western Hospital, UHN, Toronto, Canada.
  1. Correspondence
    Dr. Hodaie mojgan.hodaie{at}uhn.ca
View Full Text

Article usage

Article usage: October 2021 to July 2022

AbstractFullPdfSource
Oct 202100333Highwire
Nov 202154311699Highwire
Dec 2021108013462Highwire
Jan 20221942421Highwire
Feb 202217972Highwire
Mar 20229495Highwire
Apr 2022135125Highwire
May 20226572Highwire
Jun 20227754Highwire
Jul 202211084Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me